心脏移植患者的运动训练方式的比较有效性:随机对照试验的系统审查和网络元分析
Juliana Beust de Lima1,2, Filipe Ferrari1,2, Douglas Dos Santos Soares1
1Graduate Program in Cardiology and Cardiovascular Sciences, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS Brazil.
European journal of preventive cardiology
|September 26, 2025
概括
高强度间歇训练 (HIIT) 和联合训练 (CT) 显著改善心脏移植患者的峰值氧气消耗 (峰值VO2). 这些运动训练模式是安全和有效的,HIIT显示优越于中等强度持续训练 (MICT).
科学领域:
- 心脏病学 心脏病学
- 运动生理学 运动生理学
- 移植医学 移植医学
背景情况:
- 运动训练 (ET) 为心脏移植 (HTx) 接受者提供了好处.
- 在这个人群中,不同ET模式之间存在有限的直接比较.
研究的目的:
- 为了比较各种ET方式在HTx接受者的峰值氧气消耗 (峰值VO2) 和二次结果上的疗效和安全性.
- 确定心脏移植后恢复的最佳运动策略.
主要方法:
- 在8个数据库中进行系统的文献搜索,截至2024年9月.
- 贝叶斯网络对13项随机对照试验 (473名HTx接受者) 的元分析.
- 对网络元分析的信心 (CINeMA) 工具用于评估证据确定性.
主要成果:
- 高强度间歇训练 (HIIT) 和联合训练 (CT) 与常规护理相比,显著改善了峰值VO2.
- 在高峰VO2增强方面,HIIT表现出高于中等强度持续训练 (MICT) 的效果.
- 没有观察到心率反应或呼吸系统效率的显著差异;ET改善了生活质量,没有不良事件.
结论:
- 运动训练,特别是HIIT和CT,在改善心脏移植受体的心肺健康方面是有效的.
- HIIT成为一种非常有效的模式,在峰值VO2改善方面超过了MICT.
- 所有评估的ET模式对HTx接受者来说都是安全的,支持他们融入康复计划.
相关概念视频
Exercise and Cardiovascular Response
3.9K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.9K
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Heart Failure II: Pathophysiology
730
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
936
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936


